Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Reexamination Certificate
2002-11-04
2008-08-05
Schnizer, Richard (Department: 1635)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
C424S445000, C424S447000, C424S484000, C424S492000, C424S093200, C435S174000, C435S397000, C514S944000, C524S916000
Reexamination Certificate
active
07407672
ABSTRACT:
The invention provides a novel composition and methods of its preparation and uses. The composition comprises as main components serum and a gelling agent and is useful in various medical applications. The composition may be used to coat a medical device, as a biological glue, or as dressings, membranes, scaffolding or hydrogel useful in bioengineering applications. One or more therapeutic products may be added to the composition and the composition is also a vehicle for delivery of therapeutic products.
REFERENCES:
patent: 4526938 (1985-07-01), Churchill et al.
patent: 4716203 (1987-12-01), Casey et al.
patent: 4741337 (1988-05-01), Smith et al.
patent: 4957744 (1990-09-01), della Valle et al.
patent: 5162430 (1992-11-01), Rhee et al.
patent: 5324775 (1994-06-01), Rhee et al.
patent: 5470730 (1995-11-01), Greenberg et al.
patent: 5498259 (1996-03-01), Mourant et al.
patent: 5643192 (1997-07-01), Hirsh et al.
patent: 5833651 (1998-11-01), Donovan et al.
patent: 6129705 (2000-10-01), Grantz
patent: 6159946 (2000-12-01), Zalewski et al.
patent: 6197013 (2001-03-01), Reed et al.
patent: 6310190 (2001-10-01), Hansen et al.
patent: 6777000 (2004-08-01), Ni et al.
patent: 3214337 (1983-10-01), None
patent: 0 068 149 (1983-01-01), None
patent: 0 485 210 (1992-05-01), None
Fatah et al (Thromb. Haem. 68(2): 130-135, 1992).
Koutroubakis et al (J. Clin. Pathol. 56:817-820, 2003).
Bos et al (Thromb. Haemost. 82: 1757-1763, 1999).
Ueda et al (Clin. Exp. Immunol. 53: 217-224, 1983).
Avrameas et al (Immunochem. 6: 53-66, 1969).
Takahashi et al (Int. Arch. Allergy Appl. Immunol. 48(5): 642-652, 1975).
Kulkami et al.,Polylactic Acid for Surgical Implants, Arch Surg, vol. 93, Nov. 1966, p. 839-843.
Domb et al.Poly(anhydrides),3. poly(anhyrdrides)Based on Aliphatic-Aromatic Diacids, Macromolecules 1989, 22, 3200-3204.
Miyake et al,Solution Properties of Synthetic Polypeptides, XVIII: Helix-Coil Transition of Poly-N5-(2-Hydrozyethl)L-Glutamine, Biopolymers, vol. I3, 1173-1186 (1974).
Simon J. Holland et al.,Polymers for Biodegradable Medical Devices. 1. The Potential of Polyesters As Controlled Macromolecular Release Systems, Journal of Controlled Release, 4 (1986), 155-180.
Paul S. Teirstein et al.,Catheter-Based Radiotherapy to Inhibit Restenosis After Coronary Stenting, The New England Journal of Medicine, Jun. 12, 1977, vol. 336, No. 24, p. 1697-1703.
El Oakley Reida Menshawe
Lim Tai Tian
Peddareddigari Vijay Gopal Reddy
Klarquist & Sparkman, LLP
National Heart Center
National University of Singapore
Schnizer Richard
LandOfFree
Composition derived from biological materials and method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition derived from biological materials and method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition derived from biological materials and method of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4011266